Introducing the Charles River and Quotient Sciences Collaboration

Charles River Laboratories and Quotient Sciences are collaborating to provide seamlessly integrated programs that bridge molecules from discovery into clinical development.

There are many challenges that drug developers face when bridging from drug discovery into pre-clinical and clinical development. Traditionally, the pharmaceutical industry has been structured around different functional disciplines (“silos”), and a sponsor often has to split their drug development program across multiple service providers, including contract development and manufacturing organizations (#CDMO ) and contract research organizations (#CRO ). This places the project management burden on the sponsor, creates white space in the development timeline, limits knowledge and material sharing, and is ultimately time-consuming and costly.

To address these challenges, Charles River Laboratories and Quotient Sciences have formed a collaboration, which leverages the expertise of both companies to create a world-leading capability that supports customers from discovery through to clinical development.

Through this collaboration, Charles River’s customers can benefit from Quotient Sciences’ expertise in drug substance , drug product, and clinical testing, while Quotient Sciences’ customers can benefit from Charles River’s expertise in drug discovery, medicinal chemistry, biology, drug metabolism and pharmacokinetics (DMPK), early-stage pharmaceutics, and formulation and safety assessment. Other key benefits include reduced management burden and risk, integrated project management, and increased efficiencies by removing duplication between discovery and development partners. Together, we offer integration and a seamless transition through the discovery-to-development process.

Eleanor Row , Executive Director of Commercial at Quotient Sciences, and Russell Scammell , Director of Small Molecule Drug Discovery at Charles River, explore the unique features and benefits of the collaboration in more detail.

Continue reading now on quotientsciences.com >>